Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
M. Laiho
, O. Saksela, J. Keski-Oja
Research output
:
Contribution to journal
›
Article
›
peer-review
209
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Plasminogen Activator Inhibitor
100%
Plasmin Inhibitor
55%
Metabolic
52%
Sodium Deoxycholate
44%
Protein Synthesis
33%
Insulin Derivative
33%
Polypeptide
26%
Amount
13%
Protein
13%
Medicine & Life Sciences
Urokinase-Type Plasminogen Activator
74%
Plasminogen Activator Inhibitor 1
73%
Transforming Growth Factors
68%
Growth
10%
Plasminogen Inactivators
9%
Aprotinin
9%
Deoxycholic Acid
9%
Peptides
9%
Antifibrinolytic Agents
9%
Platelet-Derived Growth Factor
8%
Tumor Cell Line
7%
Immunoblotting
7%
Epidermal Growth Factor
7%
Immunoprecipitation
7%
Cultured Cells
6%
Molecular Weight
6%
Insulin
4%
Serum
3%
Proteins
2%